Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin (With or Without Sulfonylurea): a Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study With 24-week Treatment Period

NCT01169779 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01169779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01169779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin (With or Without Sulfonylurea): a Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study With 24-week Treatment Period
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2010
Completion date
December 31, 2011
Enrollment
391 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus